logo
Share SHARE
FONT-SIZE Plus   Neg

Novo Nordisk Says FDA Approves To Update Victoza Product Label

Novo Nordisk A/S (NVO) said Friday that the US Food and Drug Administration has approved to update the product label for Victoza to include data showing superior blood sugar control and weight reduction when compared to Januvia.
The update also includes data showing the safety and efficacy of adding basal insulin to Victoza and metformin for the treatment of adults with type 2 diabetes.

The label update is based on data from two large, randomized, open-label studies in adults with type 2 diabetes.

"The data from these studies further demonstrate the strong clinical profile and the value of Victoza in the treatment of type 2 diabetes," said Mads Krogsgaard Thomsen, executive vice president and chief science officer of Novo Nordisk.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Chipotle Mexican Grill Inc. (CMG)Monday announced that it will launch a new summertime loyalty rewards program, as the Mexican restaurant tries to lure back customers to its outlets after a series of food-related disease outbreak. The three-month-long promotion, called Chiptopia Summer Rewards, will... Japanese messaging service Line Corp. announced its decision to delay the setting of a price range for its initial public offering by one day, until Tuesday, citing the chaos caused by Brexit in global markets. Line was actually planning to announce the IPO price range on Monday, June 27, and the... Fujifilm launched a new version to its tiny instant printer line up. The new upgraded version, Instax Share SP-2, can be used to print photographs from smartphones in a faster pace.
comments powered by Disqus
Follow RTT